Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (3)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases

2023

  1. Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 531-533